Immune-Mediated Drug-Induced Liver Injury: Immunogenetics and Experimental Models
Year: 2021
Type: review
Abstract: Drug-induced liver injury (DILI) is a challenging clinical event in medicine, particularly because of its ability to present with a variety of phenotypes including that of autoimmune hepatitis or other immune mediated liver injuries. Limited diagnostic and therapeutic tools are available, mostly because its pathogenesis has remained poorly understood for decades. The recent scientific and technological advancements in genomics and immunology are paving the way for a better understanding of the molecular aspects of DILI. This review provides an updated overview of the genetic predisposition and immunological mechanisms behind the pathogenesis of DILI and presents the state-of-the-art experimental models to study DILI at the pre-clinical level.
DOI: 10.3390/ijms22094557
Institutions: Azienda Ospedaliera San Gerardo, University of Milano-Bicocca, Institute of Molecular Biology and Pathology, National Research Council, Université Libre de Bruxelles, Humanitas University, Institut Jules Bordet, IRCCS Humanitas Research Hospital, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Hospital Clínico Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga, Universidad de Málaga
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,135
OpenAlex ID: W3159227089
